Amit Sachdev

2017

In 2017, Amit Sachdev earned a total compensation of $4.9M as EVP & Chief Regulatory Officer at Vertex Pharmaceuticals, a 10% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$600,233
Option Awards$1,110,263
Salary$540,750
Stock Awards$2,625,016
Other$10,001
Total$4,886,263

Sachdev received $2.6M in stock awards, accounting for 54% of the total pay in 2017.

Sachdev also received $600.2K in non-equity incentive plan, $1.1M in option awards, $540.8K in salary and $10K in other compensation.

Rankings

In 2017, Amit Sachdev's compensation ranked 1,948th out of 14,666 executives tracked by ExecPay. In other words, Sachdev earned more than 86.7% of executives.

ClassificationRankingPercentile
All
1,948
out of 14,666
87th
Division
Manufacturing
664
out of 5,770
89th
Major group
Chemicals And Allied Products
175
out of 2,074
92nd
Industry group
Drugs
130
out of 1,730
93rd
Industry
Pharmaceutical Preparations
99
out of 1,329
93rd
Source: SEC filing on April 17, 2018.

Sachdev's colleagues

We found six more compensation records of executives who worked with Amit Sachdev at Vertex Pharmaceuticals in 2017.

2017

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2017

Michael Parini

Vertex Pharmaceuticals

EVP & Chief Legal and Administrative Officer

2017

Ian Smith

Vertex Pharmaceuticals

Chief Operating Officer

2017

David Altshuler

Vertex Pharmaceuticals

Chief Scientific Officer

2017

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2017

Thomas Graney

Vertex Pharmaceuticals

Chief Financial Officer

News

You may also like